Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of irinotecan + S-1 by UGT1A1 genotype in advanced gastric cancer
ChiCTR-OCH-12002472Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of irinotecan and tegafur in gastric cancer (GC), sponsored by West China Hospital of Sichuan University. Started May 2012; status: recruiting.
02
Drugs
irinotecantegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-OCH-12002472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-12002472.